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A B S T R A C T
Senile lentigo or age spots are hyperpigmented macules of skin that occur in irregular shapes, appearing most com-
monly in the sun- exposed areas of the skin such as on the face and back of the hands. Senile lentigo is a common compo-
nent of photoaged skin and is seen most commonly after the age of 50. There are many disscusions on whether senile
lentigo represents a melanoma precursor, namely lentigo maligna melanoma and, if there is a need for a regular follow
up in cases of multiple lesions. Clinical opservations sometimes report that in the location of the newly diagnosed mela-
noma, such lesion preexsisted. On contrary, some authors believe that senile lentigo represents a precursor of seborrheic
keratosis, which does not require a serious medical treatment. However, the opservation of the possible association of se-
nile lentigo with the melanoma development makes us cautious in the assessment of this lesion. Histologically, there are
elongated rete ridges with increased melanin at the tips, and the number of melanocytes is not increased. The dermato-
scopic features are also distinctive. If the lesion becomes inflammed it may evolve into benign lichenoid keratosis. Cryo-
therapy and laser treatment are common therapeutic approaches. Sun protection creams may be useful in early lesions.
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Introduction
Lentigo senilis (synonyms: lentigo solaris, liver spot,
old age spot, senile freckle) is well-circumscribed, round,
oval or irregularly shaped macule that vary in color from
light brown to dark brown or black which usually devel-
ops on chronically photoexposed areas in the elderly peo-
ple, predominantly on the face, the dorsal aspects of
hands, extensor forearms, the upper chest and back1.
More than one half of all patients over age 64 will have at
least one senile lentigo, and most patients have more
than one. Senile lentigines are found in 90% of the Cau-
casian poplulation older than 60 years, and according to
published epidemiological data their incidence increase
with advancing age and cumulative ultraviolet (UV) light
exposure 2,3. With respect to increased incidence of this
common skin lesion, senile lentigo has become a signifi-
cant cosmetic and medical issue. The incidence rates of
lentigines have increased worldwide over the past sev-
eral decades. The similar trend has been observed in
Croatia. The exact incidence rate is unknown since they
are considered benign lesions and not routinely added
into National Register4.
The most significant environmental factor for the de-
velopment of senile lentigo is cumulative UV radiation,
particularly solar UVB radiation5. During the past cen-
tury, changes in clothing styles, recreational activities,
chronic occupational solar exposure, longevity, and other
aspects of lifestyle have resulted in increased exposure to
sunlight. Although most UV radiation comes from the
sun, the use of sunbeds as arteficial sunlight has resulted
in a rising incidence of UV-induced lentigines. The most
important defense mechanisms in the protection of hu-
man skin against UV radiation involve melanin synthe-
sis and active repair mechanisms. Low pigmentation ca-
pacity in Caucasians and rare genodermatosis Xeroderma
pigmentosum lead to multiple senile lentigines associ-
ated with multiple skin cancers. Inherited patterned len-
tiginosis favors more lightly pigmented African-Ame-
ricans6.
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Despite their benign nature, lentigines can cause sub-
stantial cosmetic issue, with strong impact on health
care budgets due to their extraordinary high incidence.
UV Radiation and Senile Lentigo
UV radiation is well-known, potent, environmental
agent closly associated with the development of senile
lentigo in fair-skinned, elderly individuals. The concept
of UV radiation as the significant etiologic factor in the
pathogenesis of senile lentigo originates from the begin-
ning of the twentieth century followed by astute observa-
tions of clinicians who noted that senile lentigo fre-
quently appeared on the sun-damaged skin of fair-ski-
nned individuals who pursued outdoor occupations.
Within the UV radiation spectrum, the UVA (wave-
lengths between 320 and 400 nm), and particularly UVB
(wavelengths between 290 and 320 nm) are the most sig-
nificant. Besides occupational UV exposure, UV photo-
therapy has been associated with senile lentigo.
PUVA (psoralen+ UVA) lentigo is a well- circum-
scribed hyperpigmented macule that commonly develops
in individuals undergoing long-term PUVA chemother-
apy. About 50% of PUVA-treated patients develop PUVA
lentigines after average of 5 to 7 years of photochemo-
therapy. The frequency and severity of the lesions are
positively correlated with greater number of treatments,
age of starting therapy, and male sex. There is a negative
association wih skin phototypes V and VI. In contrast to
typical senile lentigines, PUVA lentigines usually exhibit
darker pigmentation and more of a stellate appearance.
Histologically, the PUVA-induced lesions display lenti-
ginous hyperplasia of larger melanocytes that often ex-
hibit mild cytologic atypia. Patients treated with PUVA
should also be monitored for the development of mela-
noma2,7.
Numerous studies have supported the notion that UV
radiation causes significant damage to keratinocytes and
melanocytes8. A case-controlled study in France found
that multiple senile lentigines on the upper back and
shoulders of adults may serve as clinical markers of past
severe sunburn and may be used to identify a population
at higher risk of developing cutaneous melanoma9. The
researchers suggested that senile lentigo may be induced
by the mutagenic effect of repeated past UV light expo-
sures, leading to characteristic enhancement of melanin
production10.
Little is known about the genetic basis of human se-
nile lentigines, which were analyzed for potential fibro-
blast growth factor receptor 3 (FGFR3) and phospha-
tidylinositol 3 CA-kinases (PIK3CA) mutations. A recent
study (Hafner et al.) investigated environmental and ge-
netic risk factors for senile lentigo. FGFR3 and PIK3CA
regulate several important cellular processes, including
regulation of cell growth and division. The FGFR3 gene
is located on the short (p) arm of at position 16.3 and
PIK3CA gene is located on the long (q) arm of at position
26.3. The FGFR3 gene mutations were detected in 17%
of senile lentigines, and PIK3CA gene mutations were
detected in 7% of senile lentigines, suggesting that FGFR3
and PIK3CA mutations are involved in their pathoge-
nesis and further substantiating previous speculations
that UV exposure may be a causative factor for FGFR3
and PIK3CA mutations in human skin11.
Furthermore, UV radiation induces the release of
prostaglandins and cytokines by the keratinocytes.
Among the mediators released by keratinocytes in re-
sponse to UV radiation, there is a small peptide en-
dothelin-1 (ET-1), a ligand for the endothelin-B (ETB) re-
ceptor expressed on melanocytes, which can lead to an
increase in tyrosinase activity followed by an increase in
melanin production. A recent report (Kadono et al.) dem-
onstrates focal epidermal ET-1 hypersecretion and en-
dothelin-B (ETB) overexpression in human skin samples
from lentigo senilis12.
The activation of the ET-1/ETB pathway downregu-
lates E-cadherin and associated catenin proteins in hu-
man melanocytes and melanoma cells. E-cadherin is an
established suppressor of melanoma cell invasion in vitro
and in vivo. Downregulation of E-cadherin, cellular ad-
hesion molecule, by ET-1/ETB receptor involves the down-
stream activation of caspase-8 but not of distal, execu-
tioner caspases, and does not lead to apoptosis13.
Interactions between keratinocytes and melanocytes
including ET-1 and ETB receptor as well as stem cell fac-
tor (SCF) and c-KIT receptor expressed on melanocytes
are responsible cytokine networks for senile lentigo and
UVB-melanosis14. Disturbed keratinocytes-melanocytes
interactions during melanosome transfer and skin me-
lanosome distribution patterns could be related to senile
lentigo formation. Melanocytes located in the basal layer
of epidermis produce melanin-loaded melanosomes, which
are distributed to neighboring keratinocytes. Chronic
UV radiation lead to an accumulation of melanosomes in
melanocytes and also increase the phagocytose of mela-
nosomes by keratinocytes15.
Affymetrix gene-expression analysis (Goyarts et al.)
was performed on mRNAs from involved and uninvolved
skin biopsies from volunteers with lentigo senilis. In this
study serine peptidase gene was downregulated in keep-
ing with the suggestion that lentigo senilis is associated
with impaired melanin degradation. The antiapoptotic
genes were downregulated, and six genes associated with
transmembrane transport of melanosomes were upre-
gulated16.
Production of the growth factors, can also lead to an
increase in the pigment content within melanocytes in
senile lentigo. There is also increasing evidence that UV
radiation can affect receptors, kinases, phosphatases and
transcription factors.
The most important defense mechanisms in the pho-
toprotection involve melanin synthesis and active repair
mechanisms. Low pigmentation capacity in Caucasians
and rare genodermatosis Xeroderma pigmentosum are
mainly responsible for protection failures.
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Clinical, Histological and Dermatoscopic
Features of Senile Lentigo
Clinical appearance and histologic features of lentigo
senilis have been well documented. Senile lentigines are
well-circumscribed, round or oval macules that vary in
color from yellow, light brown to dark brown or black.
More lightly pigmented lesions are usually homoge-
neous, whereas darker ones tend to have a mottled ap-
pearance. The lesions increase in number and in size
gradually. They usually vary from about 3 mm to 2 cm in
diameter and demonstrate a tendency towards conflu-
ence. Larger and older lesions are often irregular in
shape and are often dark brown or brownish-black in
color. Senile lentigines occur on sun-exposed areas, pre-
dominantly the dorsal aspects of hands, extensor fore-
arms, the face, the upper chest and back of fair-skinned,
elderly individuals1.
Differential diagnosis of senile lentigo includes a wide
range of benign and malignant lesions, such as early
stage of seborrheic keratosis and lentigo maligna. Der-
matoscopy as new, noninvasive diagnostic technique may
be helpful in diagnosis of senile lentigo, since senile
lentigo may mimic early stage of seborrheic keratosis,
solitary lichen planus-like keratosis (SLPLK) or lentigo
maligna.
Major dermatoscopic features of senile lentigo are: a
diffuse light brown structureless area, sharply demar-
cated and/or moth-eaten borders, fingerprinting, and a
reticular pattern with thin lines that are occasionally
short and interrupted17.
According to Nouveau et al. dermatoscopic pictures of
senile lentigo have shown that the observed structures
can be vary different within a given lesion, suggesting
that different areas of a senile lentigo could be in differ-
ent grades of severity, which proves the heterogeneity of
senile lentigo architecture18. There is clinical and histolo-
gic evidence of close relationship between lentigo senilis,
SLPLK, and reticulated form of seborrheic keratosis. In
the histologic study performed by Mehregan histologic
transformation was found from lentigo senilis into cen-
tral SLPLK.
It was concluded that SLPLK is an inflammatory
variant of lentigo senilis with irritation, trauma, or other
yet unknown factors leading to basal cell damage, lique-
faction degeneration, and incontinentia of pigment fol-
lowed by induction of an inflammatory cell reaction in a
fashion similar to that which recently has been postu-
lated to occur in lichen planus. The same study also has
shown histologic transformation from lentigo senilis into
reticulated seborrheic keratosis. Fully developed reticu-
lated seborrheic keratosis shows a more complicated net-
work pattern of pigmented basaloid cell and areas of ker-
atin cyst formation. Intention of the study performed by
Mehregan was to evaluate the possibility of relationship
between lentigo senilis and lentigo maligna. The light-
-brown area of lentigo maligna exhibits diffuse prolifera-
tion of anaplastic clear cells at the dermoepidermal junc-
tion. There is no evidence of basaloid cell proliferation or
budding and no resemblance to lentigo senilis19.
The development of melanocyte cytologic atypia in se-
nile lentigines on occasion suggests a relationship of so-
lar lentigines to lentigo maligna, but clear progression to
lentigo maligna has not been established20. Senile len-
tigines have been shown to be an independent risk factor
for the development of melanoma.Senile lentigines are
phenotypic manifestation of sun exposure. They are as-
sociated with a two-to threefold relative risk for the de-
velopment of melanoma4,20. In a study of 513 melanoma
patients these lesions were identified with increasing
age21.
A biopsy is mandatory for any lesion that develops an
irregular border and color, particularly very dark brown
or black hues. The biopsy findings in solar lentigo are
characterized by proliferation of basaloid cells forming
buds and strands that contain increased amounts of mel-
anin. In some cases, the melanocytes are increased in
number at the dermoepidermal junction. There is no
junctional activity. Melanocytes in dopa-stained sections
of solar lentigines exhibit increased melanogenesis, and
these cells have more numerous as well as longer and
thicker dendritic processes than the melanocytes of nor-
mal skin. In the superficial dermis there is the constant
finding of actinic elastosis and dermis often contains
melanophages and occasionally a mild perivascular infil-
trate of lymphocytes. Electron microscopic studies reveal
abbundant melanosome complexes in keratinocytes which
appear to be larger than in normal surrounding skin2,22.
Treatment of Senile Lentigo
Cryotherapy and laser surgery have been shown to be
equally effective, but caution must be used to prevent
post-treatment dyspigmentation. Senile lentigines may
be removed with various types of chemical peels, 2%
mequinol/0,01% tretinoin, or special lasers23. They may
also be temporarily bleached with 3-4% concentration
hydroquinone creams which are used as cytotoxic effects
to melanocytes and tyrosinase inhibitors. Another de-
pigmenting agent kojic acid interrupts intermediates in
melanin synthesis24.
Primary prevention of senile lentigo is appropriately
focused on the avoidance of excessive sun exposure of the
skin. Photoprotection is one of the fundamental preven-
tion of BCC. Dermatologists should educate their pa-
tients in the use of sunscreen. The use of a highly effec-
tive broad-spectrum UVA and UVB sunscreen have been
shown to influence the development of nevi in children,
suggesting that they should play a role in preventing se-
nile lentigines if used correctly and consistently. Combi-
nation of UVA and UVB filters may offer a powerful pro-
tection against UV-induced effects in the use of suncare
products25.
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Conclusion
Senile lentigo is an entity with distinct histologic fea-
tures characterized by proliferation and downward bud-
ding of basaloid cells accumulating melanin pigment.
There is no significant degree of proliferation of melano-
cytes and in this respect lentigo senilis is a proliferative
epidermal disorder rather than a disease of the me-
lanocytic system. There is no histologic evidence to in-
criminate lentigo senilis as an early or precursor stage of
the precancerous melanosis. However, It is crucial to rec-
ognize its role as an indication of chronic UV damage
which dictates monitoring of the patient for non-mela-
noma skin cancer and melanoma.
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LENTIGO SENILIS- KOZMETSKI ILI MEDICINSKI PROBLEM TRE]E DOBI
S A @ E T A K
Lentigo senilis (senilne pjege) podrazumijeva promjene na ko`i koje se klini~ki o~ituju kao hiperpigmentirane ma-
kule koje se naj~e{}e pojavljuju na fotoeksponiranim podru~jima kao {to su lice i dorzumi {aka. Senilni lentigo spada u
uobi~ajene komponente tzv. fotostarenja ko`e i naj~e{}e se vidi u osoba starijih od 50 godina. ^esto se vode rasprave je li
lentigo senilis prete~a melanoma, i to lentigo maligna melanoma te treba li osobe koje imaju multiple promjene redovito
kontrolirati. U klini~kim iskustvima ponekad se dobije podatak da je melanomu prethodila upravo takva lezija. Ta-
ko|er, neki autori smatraju, suprotno prethodnome, da je lentigo senilis prete~a seboreji~ke keratoze, a koja ne zahtjeva
ozbiljan medicinski tretman. No, ipak nas opservacije o poveznici senilnog lentiga s mogu}im nastankom melanoma
~ine opreznijim u opserviranju ove lezije. Histolo{ki, kod senilnog lentiga vide se produljene epidermalne pre~ke s pove-
}anom koli~inom melanina u vr{cima, dok broj melanocita nije pove}an. Dermatoskopska slika je tako|er karakte-
risti~na. Uslijed inflamatornog procesa solarni lentigo mo`e prije}i u dobro}udnu lihenoidnu keratozu. Krioterapija i
laserski tretman danas su naj~e{}e primjenjivane metode u uklanjanju senilnih pjega, a kod po~etnih promjena pri-
mjena krema s UV filtrima mo`e biti u~inkovita.
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